logo

800% Upside For This Biotech Stock - Analyst Initiates Coverage On Bladder Cancer Focused ImmunityBio - ImmunityBio ( NASDAQ:IBRX )

  3 weeks ago   
post image
EF Hutton has initiated coverage on ImmunityBio Inc. IBRX, a vertically integrated biotechnology company developing therapies and vaccines to bolster the natural immune system for cancers and infectious diseases.
Ticker Sentiment Impact
IBRX
Somewhat Bullish
38 %